Clinical Trial Results - Progress in Cancer Care
These summaries highlight recently released results from cancer clinical trials. The findings are significant enough that they are likely to influence your medical care.
The summaries are listed in reverse chronological order. You may also use the navigation tools on the left to search the summaries by keyword or type of cancer.
(Posted: 12/29/2010) - Patients with advanced non-small-cell lung cancer (NSCLC) who received cetuximab (Erbitux) plus chemotherapy lived on average 5 weeks longer than patients who received chemotherapy alone, according to results of a randomized phase III trial.
Regular Sunscreen Use May Reduce Invasive Melanoma Risk
(Posted: 12/27/2010) - Regular sunscreen use may reduce the risk of developing melanoma, according to results of a randomized controlled trial that were reported December 6, 2010, in the Journal of Clinical Oncology.
Trial Suggests New Treatment Option for Hodgkin Lymphoma
(Posted: 12/27/2010) - Intermediate results from a phase II clinical trial presented at the 2010 American Society of Hematology annual meeting indicate that an investigational agent called brentuximab vedotin may be an effective alternative for some patients with Hodgkin lymphoma who have few viable treatment options.
More Evidence Suggests Aspirin May Prevent Colorectal Cancer
(Posted: 12/07/2010) - A new meta-analysis shows that both colorectal cancer and deaths from the disease may be reduced by long-term daily use of aspirin, according to results published online October 21, 2010, in The Lancet.
Crizotinib Continues to Show Promise for Some Lung Tumors, Faces Challenge of Drug Resistance
(Posted: 12/07/2010) - New data from a phase I trial of crizotinib, a small-molecule drug that targets cancer-causing chromosomal rearrangements involving the gene ALK, in patients with non-small cell lung cancer add to positive results published October 28, 2010, in the New England Journal of Medicine.